# Correction: Tabouret et al. TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma. Cancers 2020, 12, 1935

**Authors:** Emeline Tabouret, Herui Wang, Niranjana Amin, Jinkyu Jung, Romain Appay, Jing Cui, Qi Song, Antonio Cardone, Deric M. Park, Mark R. Gilbert, Harish Pant, Zhengping Zhuang

PMC · DOI: 10.3390/cancers17193094 · Cancers · 2025-09-23

## Full-text entities

- **Genes:** CDK5R1 (cyclin dependent kinase 5 regulatory subunit 1) [NCBI Gene 8851] {aka CDK5P35, CDK5R, NCK5A, p23, p25, p35}, CDK5 (cyclin dependent kinase 5) [NCBI Gene 1020] {aka LIS7, PSSALRE}
- **Diseases:** Glioblastoma (MESH:D005909), Cancers (MESH:D009369)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12524195/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12524195/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12524195/full.md

---
Source: https://tomesphere.com/paper/PMC12524195